Received Apr 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
Administration of the Menveo 1-vial presentation to patient under 10 years of age; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced inappropriate age at vaccine administration (Verbatim: Administration of the Menveo 1-vial presentation to patient under 10 years of age). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK Receipt Date: 09-APR-2025 Pharmacist states a patient was supposed to get the Menveo 2-vial presentation (patient was under 10 years of age) but received the 1-vial presentation instead, which led inappropriate age at vaccine administration. The health care professional declined that contact information be stored and declined to provide any additional information, therefore did not probe any further. The reporter did not consent to follow-up.